HJB

HJB, a subsidiary of Transcenta Holding Limited, is dedicated to providing high quality, speedy and flexible CDMO services for large molecules. We apply and are continuously developing highly efficient technology platforms, operation strategy and manufacturing facilities for rapid development of effective biotherapeutics and for production at the lowest possible cost. HJB has established sites in China and the US, both supported by a team of over 200 experienced process scientists, engineers and biological manufacturing experts. The state-of-the-art Hangzhou Manufacturing GMP Facility exemplifies most advanced biological process technology and facility design. It employs Integrated Continuous Bioprocessing Platform and flexible T-BLOC modular...

Molecule design/ engineering,process development,analytical development,formulation & drug product development,plant design/ engineering,and clinical manufacturing

Hjb operates in the Pharmaceutical manufacturing industry.

Hjb's revenue is 11m - 100m

Hjb has 51 - 200 employees.